Obesity Dosing of High Dose Melphalan in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant

Key Points

• Obesity affects dosing strategies for high dose melphalan in multiple myeloma treatment.
• Key metrics indicate that appropriate dosages are crucial for treatment efficacy and safety.
• Analysis evaluates parameters in patients undergoing autologous hematopoietic cell transplant.
• The findings underscore the need for personalized treatment plans to enhance outcomes in this patient population.